| Date Filed | Type | Description |
| 05/08/2023 |
3
| Pellegrino Mark N (CFO, Secretary, Treasurer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
3
| Kirkov Kirko (Chief Commercial Officer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 08/29/2022 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 459,536 shares
@ $0.0435, valued at
$20k
|
|
| 08/29/2022 |
4
| Caskey Davis S (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 459,536 shares
@ $0.0435, valued at
$20k
|
|
| 08/29/2022 |
4
| Dash Barry H (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 459,536 shares
@ $0.0435, valued at
$20k
|
|
| 07/07/2022 |
4
| Chen Robert C J (CFO, Secretary, Treasurer) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 900,000 options
@ $0.04, valued at
$36k
|
|
| 06/03/2022 |
3
| Chen Robert C J (CFO, Secretary, Treasurer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 07/07/2021 |
4
| Bregman Marc (CFO, Secretary, Treasurer) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 300,000 options
@ $0.0562, valued at
$16.9k
|
|
| 07/01/2021 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 295,570 shares
@ $0.0677, valued at
$20k
|
|
| 07/01/2021 |
4
| Caskey Davis S (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 295,570 shares
@ $0.0677, valued at
$20k
|
|
| 07/01/2021 |
4
| Dash Barry H (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 295,570 shares
@ $0.0677, valued at
$20k
|
|
| 05/19/2021 |
3
| Bregman Marc (CFO, Secretary, Treasurer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Plassche Douglas (SVP of Operations) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 574,597 shares
@ $0.087, valued at
$50k
|
|
| 02/27/2018 |
4
| Pfeifer Eugene M (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 161,374 shares
@ $0.1239, valued at
$20k
|
|
| 02/27/2018 |
4
| Plassche Douglas (SVP of Operations) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 201,717 shares
@ $0.1239, valued at
$25k
|
|
| 02/27/2018 |
4
| Ward Carter Julian (CFO, Sec., Treas.) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 242,060 shares
@ $0.1239, valued at
$30k
|
|
| 02/27/2018 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 161,374 shares
@ $0.1239, valued at
$20k
|
|
| 02/27/2018 |
4
| Dash Barry H (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 161,374 shares
@ $0.1239, valued at
$20k
|
|
| 02/27/2018 |
4
| Caskey Davis S (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 161,374 shares
@ $0.1239, valued at
$20k
|
|
| 05/03/2017 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Disposed of 158,017,321 shares
@ $0
Acquired 24 options to buy
@ $1000000, valued at
$24M
Acquired 79,008,661 warrants
@ $0.1521, valued at
$12M
|
|
| 02/27/2017 |
4
| Pfeifer Eugene M (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 72,040 shares
@ $0.2025, valued at
$14.6k
|
|
| 02/27/2017 |
4
| Caskey Davis S (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 68,518 shares
@ $0.1962, valued at
$13.4k
|
|
| 02/27/2017 |
4
| Plassche Douglas (SVP of Operations) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 110,849 shares
@ $0.2255, valued at
$25k
|
|
| 02/27/2017 |
4
| Ward Carter Julian (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 133,019 shares
@ $0.2255, valued at
$30k
|
|
| 02/27/2017 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 88,679 shares
@ $0.2255, valued at
$20k
|
|
| 02/27/2017 |
4
| Dash Barry H (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 88,679 shares
@ $0.2255, valued at
$20k
|
|
| 02/27/2017 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 2,216,992 shares
@ $0.2255, valued at
$499.9k
|
|
| 08/19/2016 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/ |
|